QT-interval parameters are increased in systemic lupus erythematosus patients

Lupus

Volumn 14, Issue 10, 2005, Pages 846-852

  Cardoso, Claudia R L ^a,b   Sales, M A O ^a   Papi, J A S ^a   Salles, G F ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b NONE   (Brazil)

Author keywords

Cardiovascular risk; Electrocardiogram; Left ventricular hypertrophy; QT interval; Systemic lupus erythematosus

Indexed keywords

ADULT; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CALCULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ACTIVITY; ELECTROCARDIOGRAPHY; FEMALE; HEART ATRIUM ENLARGEMENT; HEART LEFT VENTRICLE HYPERTROPHY; HEART RATE; HUMAN; HYPERTENSION; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; OUTPATIENT; PARAMETER; PRIORITY JOURNAL; QT DISPERSION; QT PROLONGATION; RISK FACTOR; SCORING SYSTEM; ST SEGMENT; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ATRIAL FUNCTION, LEFT; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIA; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; LONG QT SYNDROME; LUPUS ERYTHEMATOSUS, SYSTEMIC; RISK FACTORS;

EID: 27744593641     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203305lu2225oa     Document Type: Article

References (44)

1. Ward MM, Pyun E, Studenski S. Causes of death in systemic lupus erythematosus: long-term follow-up of an inception cohort. Arthritis Rheum 1995; 38: 1492-1499.
2. Abu-Shakra M, Urowitz MB, Gladman DD, Gough J. Mortality studies in systemic lupus erythematosus: results from a single center. I: causes of death.J Rheumatol 1995; 22: 1259-1264.
3. Jacobsen S, Petersen J, Ulman S et al. Mortality and causes of death of 513 Danish patients with systemic lupus erythematosus. Scand J Rheumatol 1999; 28: 75-80.
4. Schattner A. The cardiovascular burden of lupus. Arch Intern Med 2003; 163: 1507-1509.
5. Manzi S, Meilahn EN, Rairia JE et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997; 145: 408-415.
6. Ward MM. Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum 1999; 42: 338-346.
7. Peters RW, Byington RP, Barker A, Yusuf S, for the BHAT Study Group. Prognostic value of prolonged ventricular repolarization following myocardial infarction: the BHAT experience. J Clin Epidemiol 1990; 43: 167-172.
8. Naas AAO, Davidson NC, Thompson C et al. QT and QTc dispersion are accurate predictors of cardiac death in newly diagnosed non-insulin-dependent diabetes: cohort study. Br Med J 1998; 316: 745-746.
9. Salles GF, Bloch KV, Cardoso CRL. Mortality and predictors of mortality in a cohort of Brazilian type 2 diabetes mellitus patients. Diab Care 2004; 27: 1299-1305.
10. Dekker JM, Schouten EG, Klootwijk P, Pool J, Krombout D. Association between QT interval and coronary heart disease in middle-aged and elderly men: the Zutphen study. Circulation 1994; 90: 779-785.
11. Elming H, Holm E, Jun L et al. The prognostic value of the QT interval and QT interval dispersion in all-cause and cardiac mortality and morbidity in a population of Danish citizens. Eur Heart J 1998; 19: 1391-1400.
12. de Bruyne MC, Hoes AW, Kors JA, Hofman A, van Bemmel JH, Grobbee DE. Prolonged QT interval predicts cardiac and all-cause mortality in the elderly. The Rotterdam Study. Eur Heart J 1999; 20: 278-284.
13. Okin PM, Devereux RB, Howard BV et al. Assessment of QT interval and QT dispersion for prediction of all-cause and cardiovascular mortality in American Indians. The Strong Heart Study. Circulation 2000; 101: 61-66.
14. Dekker JM, Crow RS, Hannan PJ, Schouten EG, Folsom AR. Heart rate-corrected QT interval prolongation predicts risk of coronary heart disease in black and white middle-aged men and women. The ARIC Study. J Am Coll Cardiol 2004; 43: 565-571.
15. Tan EN, Cohen AS, Fries JF et al. The revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
16. Gladman D, Ginzler E, Goldsmith C et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996; 39: 363-369.
17. Prineas RJ, Crow RS, Blackburn H. The Minnesota code manual of electrocardiographic findings, standards and procedures for measurement and classification. Littleton, MA: J. Wright, 1982.
18. Bombadier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992; 35: 630-640.
19. Day CP, McComb JM, Campbell RWF. QT dispersion: an indication of arrhythmia risk in patients with long QT intervals. Br Heart J 1990; 63: 342-344.
20. Bland JM, Altman DG. Statistical methods for assessing agreements between two methods of clinical measurement. Lancet 1986; 1: 307-310.
21. Svenungsson E, Jensen-Urstad K, Heimbürger M et al. Risk factors for cardiovascular disease in systemic lupus erythematosus. Circulation 2001; 104: 1887-1893.
22. Manger K, Kusus M, Forster C et al. Factors associated with coronary artery calcification in young female patients with SLE. Ann Rheum Dis 2003; 62: 846-850.
23. Sella EMC, Sato EI, Leite WA, Oliveira Filho JA, Barbieri A. Myocardial perfusion scintigraphy and coronary disease risk factors in systemic lupus erythematosus. Ann Rheum Dis 2003; 63: 1066-1070.
24. Theodoridou A, Bento L, D'Cruz DP, Khamashta MA, Hughes GRV. Prevalence and associations of an abnormal ankle-brachial index in systemic lupus erythematosus: a pilot study. Ann Rheum Dis 2003; 62: 1199-1203.
25. Roman MJ, Shanker BA, Davis A et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003; 349: 2399-2405.
26. Asanuma Y, Oeser A, Shintani AK et al. Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003; 349: 2407-2415.
27. Rautaharju PM, Manolio TA, Psaty BM, Borhani NO, Furberg CD, for the Cardiovascular Health Study Collaborative Research Group. Correlates of QT prolongation in older adults (the Cardiovascular Health Study). Am J Cardiol 1994; 73: 999-1002.
28. Pesta A, D'Agostino Jr R, Rautaharju P, Mykkänen L, Haffner SM. Relation of systemic blood pressure, left ventricular mass, insulin sensitivity, and coronary artery disease to QT interval duration in nondiabetic and type 2 diabetic subjects. Am J Cardiol 2000; 86: 1117-1122.
29. Brown DW, Giles WH, Greenlund KJ, Valdez R, Croft JB. Impaired fasting glucose, diabetes mellitus and cardiovascular disease risk factors are associated with prolonged QTc duration. Results from the Third National Health and Nutrition Examination Survey. J Cardiovasc Risk 2001; 8: 227-233.
30. Dekker JM, Feskens EJ, Schouten EG, Klootwijk P, Pool J, Kromhout D. QTc duration is associated with levels of insulin and glucose tolerance. The Zutphen Elderly Study. Diabetes 1996; 45: 376-380.
31. Festa A, D'Agostino R, Rautaharju P et al. Is QT interval a marker of subclinical atherosclerosis in nondiabetic subjects? The Insulin Resistance Atherosclerosis Study (IRAS). Stroke 1999; 30: 1566-1571.
32. Takebayashi K, Aso Y, Matsutomo R, Wakabayashi S, Inukai T. Association between the corrected QT intervals and combined intimal-medial thickness of the carotid artery in patients with type 2 diabetes. Metabolism 2004; 53: 1152-1157.
33. Rutter MK, Viswanath S, McComb JM, Kesteven P, Marshall SM. QT prolongation in patients with type 2 diabetes and microalbuminuria. Clin Auton Res 2002; 12: 366-372.
34. Schanberg LE, Sandborg C. Dyslipoproteinemia and premature atherosclerosis in pediatric systemic lupus erythematosus. Curr Rheumatol Rep 2004; 6: 425-433.
35. Prineas RJ, Grandits G, Rautaharju PM, Cohen JD, Zhang ZM, Crow RS, for the MRFIT Research Group. Long-term prognostic significance of isolated minor electrocardiographic T-wave abnormalities in middle-aged men free of clinical cardiovascular disease (The Multiple Risk Factor Intervention Trial [MRFIT]). Am J Cardiol 2002; 90: 1391-1395.
36. Greenland P, Xie X, Liu K et al. Impact of minor electrocardiographic ST-segment and/or T-wave abnormalities on cardiovascular mortality during long-term follow-up. Am J Cardiol 2003; 91: 1068-1074.
37. Zaidi M, Fesler R, Derwael C, De Kock M, Brohet CR. Computer-assisted study of ECG indices of the dispersion of ventricular repolarization. J Electrocardiol 1996; 29: 199-211.
38. Macfarlane PW, McLaughlin SC, Rodger C. Influence of lead selection and population on automated measurement of QT dispersion. Circulation 1998; 98: 2160-2167.
39. Bortolan G, Bressan M, Golferini F. QT dispersion in the elderly. The ILSA Study. Aging Clin Exp Res 2004; 16: 342-348.
40. Cimaz R, Stramba-Badiale M, Brucato A, Catelli L, Panzeri P, Meroni PL. QT interval prolongation in asymptomatic anti-SSA/Ro-positive infants without congenital heart block. Arthritis Rheum 2000; 43: 1049-1053.
41. Lazzerini PE, Acampa M, Guideri F et al. Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA-positive connective tissue diseases. Arthritis Rheum 2004; 50: 1248-1252.
42. Costedoat-Chalumeau N, Amoura Z, Lupoglazoff JM et al. Outcome of pregnancies in patients with Ant-SSA/Ro antibodies. Arthritis Rheum 2004; 50: 3187-3194.
43. Gordon PA, Rosenthal E, Khamashta MA, Hughes GR. Absence of conduction defects in the electrocardiograms of mothers with children with congenital complete heart block. J Rheumatol 2001; 28: 366-369.
44. Costedoat-Chalumeau N, Amoura Z, Duhaut P et al. Safety of hydroxycloroquine in pregnant patients with connective tissue diseases. Arthritis Rheum 2003; 48: 3207-3211.